Brijesh Shah
About Brijesh Shah
Brijesh Shah is the Associate Marketing Director (Metabolics) at Bristol-Myers Squibb in Mumbai, with nearly 17 years of experience in pharmaceutical sales management.
Current Role at Bristol-Myers Squibb
Brijesh Shah is currently working as an Associate Marketing Director (Metabolics) at Bristol-Myers Squibb in Mumbai. In his role, Shah collaborates with the global team to provide strategic leadership in marketing and business management for the metabolics division. He has been instrumental in the successful launch of products such as Kombiglyze XR.
Previous Positions at Bristol-Myers Squibb
Prior to his current role, Brijesh Shah worked at Bristol-Myers Squibb as the National Sales Manager for the C.V & Met division from 2010 to 2011. Based in the Mumbai Area, India, he contributed significantly to sales strategies and business management within the cardiovascular and metabolic sectors.
Career at Bayer Schering Pharma and Bayer
Brijesh Shah has held numerous roles at Bayer Schering Pharma and Bayer. From 2009 to 2010, he was a Regional Business Manager for the diabetic cardiac division at Bayer Schering Pharma. He also served as an Area Business Manager at Bayer from 2006 to 2008 and as an Area Sales Manager from 2004 to 2006. Additionally, Shah gained experience as a Medical Representative at Bayer India Ltd from 1995 to 1999.
Academic Background
Brijesh Shah holds a Diploma in Business Management from Welingkar Institute of Management, which he earned from 2009 to 2010. He also has a Bachelor of Science degree in Chemistry, obtained from Software Engineering Jobs, where he studied from 1992 to 1995.
Specialization and Expertise
With nearly 17 years of experience in pharmaceutical sales management, Brijesh Shah specializes in pharma sales and marketing, strategic management, talent management, team building, KOL development, product launches, and alliance management. He has successfully prepared the market for important product launches and maintains effective alliances, such as his collaboration with AstraZeneca on specific projects.